ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,342Medicare Part D Prescriptions Filled, Including Refills

Rank: 119 out of 1942

$572K Total Retail Price of All Prescriptions

Rank: 44 out of 1942

456 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 6,523 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 624 432 1 1
HYDROCODONE-ACETAMINOPHEN 349 262 S3 2 12
OMEPRAZOLE 297 194 3 4
LISINOPRIL 274 207 4 2
FUROSEMIDE 263 217 5 5
LEVOTHYROXINE SODIUM 239 151 6 3
METOPROLOL TARTRATE 228 190 7 9
AMLODIPINE BESYLATE 206 162 8 6
METFORMIN HCL 187 121 9 10
HYDROCHLOROTHIAZIDE 182 142 10 8
CITALOPRAM HBR 177 108 11 15
METOPROLOL SUCCINATE 168 126 12 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 159 114 13 22
ZOLPIDEM TARTRATE 157 87 14 25
ATENOLOL 136 133 15 7
DICLOFENAC SODIUM 133 74 16 136
WARFARIN SODIUM 130 100 17 11
TRAMADOL HCL 129 79 18 19
PREDNISONE 125 96 19 27
POLYETHYLENE GLYCOL 3350 123 90 20 28
POTASSIUM CHLORIDE 116 88 21 17
OXYCODONE HCL 113 39 S2 22 52
AMITRIPTYLINE HCL 110 67 R 23 65
TRAZODONE HCL 108 51 24 24
PROAIR HFA 102 51 25 41
GLIMEPIRIDE 92 71 26 53
ADVAIR DISKUS 91 49 27 35
TAMSULOSIN HCL 89 77 28 29
VENLAFAXINE HCL ER 86 61 29 70
SERTRALINE HCL 85 66 30 20
JANUVIA 81 65 31 85
TRIAMCINOLONE ACETONIDE 79 51 32 71
ALENDRONATE SODIUM 65 49 33 21
ALLOPURINOL 65 47 33 26
CARBIDOPA-LEVODOPA 61 41 35 64
JANTOVEN 53 23 36 33
DONEPEZIL HCL 52 52 37 30
RAMIPRIL 52 49 37 111
FENTANYL 51 51 S2 39 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.